Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and ...

Novocure today reported financial results for the first quarter ended March 31, 2025. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by ...

The finest clothing made is a person's own skin, but, of course, society demands something more than this.” – Mark Twain ...

The next routine forecast will be issued at 6:05 am EST Friday.